Transfection of Kasumi-1 cells with a new type of polymer carriers loaded with miR-155 and antago-miR-155

Previous studies have demonstrated functional roles for microRNAs (miRNAs) in various aspects of normal and malignant hematopoiesis, including lineage commitment, differentiation, apoptosis and maturation. In vivo delivery of naked DNA, oligonucleotides and miRNAs is complicated by their low stabili...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer gene therapy Jg. 20; H. 4; S. 237 - 241
Hauptverfasser:	Klimenko, O V, Shtilman, M I
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Nature Publishing Group US 01.04.2013 Nature Publishing Group
Schlagworte:	631/337/384/331 631/61/2300/1851 631/61/51/391 692/699/67/1990 Apoptosis Biomedical and Life Sciences Biomedicine Biopolymers Cell Line, Tumor Cell Shape Core Binding Factor Alpha 2 Subunit - genetics Core Binding Factor Alpha 2 Subunit - metabolism Cytogenetics Cytology fms-Like Tyrosine Kinase 3 - genetics fms-Like Tyrosine Kinase 3 - metabolism Gene Expression Gene Therapy Genetic Therapy Health aspects Humans Leukemia Luminescent Proteins - biosynthesis Luminescent Proteins - genetics MicroRNA MicroRNAs - genetics Microscopy, Fluorescence miRNA Nanoparticles - chemistry Octamer Transcription Factor-3 - genetics Octamer Transcription Factor-3 - metabolism Oligonucleotides Oncogene Proteins, Fusion - genetics Oncogene Proteins, Fusion - metabolism original-article Physiological aspects Platelets Polymers Polyvinyls - chemistry Polyvinyls - metabolism Proto-Oncogene Proteins c-kit - genetics Proto-Oncogene Proteins c-kit - metabolism Red Fluorescent Protein RNA Interference RNA-Binding Proteins - genetics RNA-Binding Proteins - metabolism RUNX1 Translocation Partner 1 Protein Transfection Russia polymer carriers Kasumi-1 miR-155 platelets transfection
ISSN:	0929-1903, 1476-5500, 1476-5500
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!